ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Vodafone Group plc

Vodafone Group plc (V1OD34M)

24.96
0.00
(0.00%)
Closed February 10 3:55PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
24.96
Bid
0.00
Ask
0.00
Volume
316
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
24.96
Open
-
Last Trade
158
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

V1OD34M - Frequently Asked Questions (FAQ)

What is the current Vodafone share price?
The current share price of Vodafone is R$ 24.96
What is the 1 year trading range for Vodafone share price?
Vodafone has traded in the range of R$ 0.00 to R$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RPAD3Alfa Holdings Sa (ex Real Sa Participacoes Administracao)
R$ 5.44
(30.46%)
3.1k
CTKA3Karsten Sa ex Cia Textil Karsten
R$ 32.70
(16.83%)
200
AMOB3Automob Participacoes Sa
R$ 0.29
(16.00%)
49.09M
PGMN11Empreendimentos Pague Menos S.A.
R$ 0.30
(11.11%)
300
FICT3Fictor Alimentos S.A.
R$ 3.49
(9.06%)
109.3k
BMIN4Bco Mercantil Invests Sa
R$ 18.91
(-21.11%)
21.8k
AZEV11Azevedo Travassos Sa
R$ 0.27
(-15.63%)
35.7k
CTSA4Cia Tecidos Santanense
R$ 0.81
(-14.74%)
5.6k
RNEW11Renova Energia SA
R$ 3.06
(-9.20%)
24.9k
BMIN3Bco Mercantil Invests Sa
R$ 19.71
(-8.28%)
100
HAPV3Hapvida Participacoes Investimento SA
R$ 2.34
(0.43%)
62.06M
COGN3CognaEducacao SA
R$ 1.61
(5.92%)
59.84M
ABEV3Ambev SA
R$ 10.97
(1.11%)
50.52M
AMOB3Automob Participacoes Sa
R$ 0.29
(16.00%)
49.09M
ITUB4Itau Unibanco Holding SA
R$ 34.29
(1.09%)
37.68M

Discussion

View Full Feed
LakeshoreLeo1953 LakeshoreLeo1953 5 minutes ago
That you are asking the question probably gives you the answer.
20% is useful for continued dialogue
60% is likely juvenile posturing with
little tethering to reality.
10% is paid hype
10% is paid trash talk
I wouldn’t even rollover for those jobs
and
AVXL
Bubae Bubae 5 minutes ago
A little help with your rocketry analogies maybe? How about "rapid unscheduled disassembly" 🙃 The stock was dropped 38% between your December 10th comment to December 17th. We are down 59% from the liftoff statement of December 26th. You have been here since the October promotion that fleece
RDAR
janice shell janice shell 6 minutes ago
Now you can be an Iggles Expert. Become a auperfan!
dukeb dukeb 7 minutes ago
I think it's pretty obvious what HMBL has in store for those vacant lots. Take a look at the image below. It's a PERFECT FIT!

https://investorshub.advfn.com/uimage/uploads/2025/2/10/onclgDisneyland.png
HMBL
9Coastal 9Coastal 7 minutes ago
True. June will sneak up before long. For the moment, I'm going with no news is good news. I'm sure they are aligning and want an IPO as much as we.
WHEN
sirant sirant 7 minutes ago
Yep that's what I am thinking also. 

GO $MCIC 
MCIC
stealofadeal stealofadeal 7 minutes ago
$KRTL No selling so next leg up coming.
KRTL
misterfishman misterfishman 9 minutes ago
True and no less than .25 cents in future.
IGPK
TucsonPhil TucsonPhil 10 minutes ago
Crickets
KGKG
gorbec1 gorbec1 10 minutes ago
Yep sounds right
MCIC
BullNBear52 BullNBear52 10 minutes ago
Chocolate-Amaretto Pudding Cake

I've had that before without the Amaretto.
Serve this warm with a scoop (or two) of creamy vanilla ice cream to help balance the rich flavor of the chocolate...

Oh my wife would eat it if it has chocolate in it. Then get up early
janice shell janice shell 10 minutes ago
That makes sense. People watch and play basketball all over the world. But if the Saudis want to do that, they'll have competition.
misterfishman misterfishman 11 minutes ago
Its a scam nothing more.
KEGS
Brapp Brapp 11 minutes ago
Beautifully real and deliciously petty.

On my front, I shifted production to NGLs today. I should apply for one of those plant derived carbon neutral credits.
TGLO
newmedman newmedman 12 minutes ago
Expect more of that in the future. That's why we need to be really diligent now. Especially with all these mentally challenged individuals that bet their lives on the next tweet.

The truth must be told.

[yt]2FBACT2XbXw[/yt]
DoF DoF 12 minutes ago
Social Safe is already trademarked to World Data Exchange Holdings Pty Ltd, 160 Hawkesbury Road, Westmead, NSW, via the USPTO/
HPNN
katiesdad7 katiesdad7 12 minutes ago
AI agrees with me that the 15th is about right for an update. However the company may just stay silent and not release anything.  This may be a smart move. As the old saying goes no news is good news. 

We all feel the pain and want something to happen. 
CBRF
Skankhunt43 Skankhunt43 12 minutes ago
"We're all dennis down here"
DPLS
SkyLimit2022 SkyLimit2022 13 minutes ago
xkr,

Thanks for asking again 😶

I encourage you to seek your own reliable sources and conduct thorough research for yourself…

In my view as an individual investor, there is no known limit to the potential combinations for DCVax-L, Direct, or the Ro
NWBO
WALLnut WALLnut 13 minutes ago
Your 'one and done' fantasy is nothing but marketing smoke—and your Betaglue YntraDose is just a tired, overhyped gimmick. In real oncology, treatments evolve with adaptive, multi-dose regimens. Radiogel’s smart, precise approach leaves one-shot promises like Betaglue YntraDose in the dust.
RDGL
jackson73 jackson73 13 minutes ago
MGOL, BHAT, OCEA ww ah action for tomorrow 
BHAT MGOL OCEA
fuagf fuagf 13 minutes ago
On protection if vaccinated 30-40 years ago can't see anything either, yet. This 25 years old no help on that

Protection after Two Doses of Measles Vaccine Is Independent of Interval between Doses Get access Arrow
, , , , ,
The Journal of Infectious Diseases, Volume 1
blackcat blackcat 13 minutes ago
And that could give a whole new meaning to "The Empire Strikes back"!!
Student of the Game Student of the Game 14 minutes ago
There are MANY drugs in various stages of clinical and preclinical trials for Alzheimers disease, and there won't be just one winner. The Acumen drug Sabirnitug looks to have a better safety profile against ARIA and has a totally different target mechanism than approved drugs. The current Phase II
ABOS

Your Recent History

Delayed Upgrade Clock